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INTRODUCTION
Dengue Fever / Dengue Haemorrhagic fever is increasingly recognized as
one of the world’s major emerging infectious tropical diseases having the
potential of causing large scale outbreaks. (1) According to WHO, Dengue fever
or Dengue haemorrhagic fever is considered as the second most important
tropical disease next to malaria. (2) It  is  endemic  in  >  100  countries  in  the
tropical and subtropical regions of the world. (3) In India, the first evidence
about the occurrence of dengue fever was reported during 1956 from Vellore
district in Tamil Nadu. The first DHF outbreak occurred in Calcutta (Kolkata,
West Bengal) in 1963 with 30% of cases showing haemorrhagic manifestations.
The risk of dengue has shown an increase in recent years due to rapid,
urbanization, life style changes and deficient water management. Annually there
are 100 million new dengue viral infections reported worldwide with 5 lakh
cases of Dengue haemorrhagic fever (DHF) and Dengue shock syndrome
(DSS). (4)
Clinically Dengue infection manifests as wide spectrum of illness
ranging from undifferentiated dengue fever, fatal Dengue haemorrhagic fever
and Dengue shock syndrome which can finally lead to death through increased
vascular permeability and shock.(5)  One  of  the  primary  problems  in
management of dengue is misinterpretation  of the term haemorrhagic fever,
which implies a significant haemorrhagic component to the patho-physiology
and thus overshadowing the capillary leak syndrome occurring due to
increased permeability, which causes depletion of the intravascular component.
Capillary leak syndrome /CLS is the principal pathologic event in
causation of DHF and dengue shock syndrome (DSS). CLS broadly is
characterized by hypotension with hemoconcentration, hypoalbuminemia
without albuminuria and generalized edema. (6)
Ultrasound can be used as an early predictor as well as an important
prognostic sign for severe dengue infection especially during an epidemic. The
common ultrasonographic features that were significantly associated with
severe dengue infection were gall bladder wall thickening, ascites, pleural
effusion, pericardial effusion, pericholecystic fluid, hepatomegaly,
splenomegaly and mesenteric adenopathy. (7)
In addition to the above features, in view of hepatosplanchnic circulatory
dysfunction in acute hepatic infection in cases of dengue hemorrhagic fever,
portal venous changes are anticipated.
Early diagnosis of CLS is essential to start volume replacement and
avoid progression to DSS. Thus this study is intended to evaluate the
ultrasonographic features of  capillary leak syndrome and   investigate the role
of Doppler study of the portal vein as a predictor for capillary leakage in these
patients.

REVIEW OF LITERATURE
Motla M, Manaktala S, Gupta V, et al did  a retrospective analysis of
ultrasonographic (USG) features in patients presenting with probable dengue
fever during the outbreak of DF of 2006 in North India and found that the most
common ultrasonographic feature was ascites (74.6%) followed by gall bladder
wall edema (72%), hepatomegaly (46.2%), splenomegaly (39.1%),
pericholecystic collection (37.3%); right sided pleural effusion (28.4%)  and
bilateral effusion   (11.2%). They concluded that Ultrasonographic evidence of
ascites, pleuro-pericardial effusion, and gallbladder wall edema were non-
invasive, rapidly acquired markers of dengue and could  be helpful even before
serological investigations become available . (8)
Venkata  Sai  PM,  Dev  B,  Krishnan  R in  their  study  titled  “Role  of
ultrasound in dengue fever” demonstrated the importance of ultrasound as an
adjunct to clinical and laboratory profile in diagnosing dengue fever and
determined the usefulness of ultrasound in predicting the severity of the disease.
They also concluded that, in an epidemic of dengue, ultrasound features of
thickened gall bladder wall, pleural effusion and ascites strongly favoured the
diagnosis of dengue fever.(9)
Pramuljo  H  S,  Harun  S  R, in 1991 evaluated the ultrasonographic
features of  dengue haemorrhagic fever in paediatric age group and found that
ascites and right sided pleural effusion were more commonly associated with
DHF.(10)
Also in a observational retrospective study by Khurram M, Qayyum W,
Umar M, et al conducted in 2013, it was found that mild ascites and mild right
pleural effusion were the commonest pattern of ultrasonographic leak in dengue
haemorrhagic fever patients. (11)
This was in contradiction to the study done by Bharath Kumar Reddy
KR, et  al  , where gall bladder wall edema was commonly found in more than
75% of the patients.(12)
In 2015, Hu T, Liu J, Guan W, et al demonstrated the main CT findings
of severe dengue fever patients in chest and abdomen with the main
performances being pleural effusion, patchy clouding opacities, atelectasis,
nodules and pericardial effusion, ascites, space occupying lesions in liver,
hematoma and nephropathy. (13)
The study titled “Patterns of Gall Bladder Wall Thickening in Dengue
Fever: A Mirror of the Severity of Disease” revealed  4  distinct  patterns  of
gall bladder wall thickening. The uniform echogenic pattern was found to be
more prevalent in dengue fever without warning signs, while the honeycomb
pattern was found to be more prevalent in severe dengue fever. A change in the
pattern of gall bladder wall thickening on subsequent serial ultrasound can
predict the severity of the disease.(14)
Studies regarding the portal venous doppler changes in dengue fever are
very limited. Instead several studies have been conducted to demonstrate the
portal venous doppler changes in other causes of  high resistance in the hepatic
sinusoidal capillary network.
The congestion index described by Moriyasu and others has been used
to diagnose portal hypertension. It looks at the increase in the cross-sectional
area of the portal vein and the reduction in velocity. The index is calculated
from  the  ratio  of  the  cross-sectional  area  of  the  portal  vein  (cm2)  and  the
average flow velocity (cm/sec), with values 0.07 cm/sec considered normal. (15)
In  a   study  to  assess  the  hemodynamic  arterial  and  venous  flow  of  the
liver and spleen by using Doppler ultrasound in patients with liver cirrhosis and
portal hypertension compared with healthy subjects, conducted by Achim CA,
Bordei  P,  Dumitru  E in 2016,  it was found that larger portal vein diameter,
lower mean portal vein velocity, significantly decreased portal vein blood flow,
increased  portal vein congestion index (CI) was seen in portal hypertension
patients  than  the  controls  .  The  study  also  revealed  the  degree  of  change  in
portal venous Doppler parameters correlated with the severity of liver cirrhosis.
(16)
Characteristic features of liver cirrhosis are decreasing portal blood-flow
velocity, disappearance of pulsatility, change in flow detection in the portal vein
from hepatopetal to hepatofugal in more severe cases, and increase of resistive
index in the hepatic artery. (17)
Erdogmus B, et al suggested that the alteration in Doppler waveform
pattern of portal vein as indicated by decreased portal vein flow in fatty liver
population was due to reduced vascular compliance in liver. (18)
DENGUE EPIDEMIOLOGY (19)
The Epidemiology of dengue is a complex phenomenon that mainly
depends upon an intricate relationship between the 3 epidemiological factors:
the host (man and mosquito), the agent (virus) and the environment (abiotic and
biotic factors). The complexity of relationship among these factors eventually
determines the level of endemicity in an area.(19)
AGENT FACTOR
The dengue viruses are the members of the genus flavivirus. These small
(50nm) viruses contain single stranded RNA. There are four virus serotypes,
which are designated as DEN-1, DEN-2, DEN-3 and DEN-4(19).
VECTOR
Dengue viruses are transmitted by the bite of female Aedes (Ae)
mosquitoes. In India Ae. aegypti is the main vector in most urban areas;
however, Ae .albopictus  is also found as vector in few areas of southern India.
It is a day time feeder and can fly up to a limited distance of 400 meters. To get
one full blood meal the mosquito has to feed on several persons, infecting all of
them. (19)
ENVIRONMENTAL FACTORS
The population of Ae. aegypti fluctuates with rainfall and water storage.
Its life span is influenced by temperature and humidity, survives best between
16”-30” C and a relative humidity of 60-80%. Ae. aegypti breeds almost
entirely in domestic man-made water receptacles, in and around the houses (19).
HOST FACTOR
Dengue virus infects humans and several species of lower primates but in
India man is the only natural reservoir of infection. All ages and both sexes are
susceptible to dengue fever. Secondary dengue infection is a risk factor for DHF
including passively acquired antibodies in infants. Travel to dengue endemic
area is an important risk factor.
TRANSMISSION CYCLE
The female Ae. aegypti usually becomes infected with dengue virus when
it takes blood meal from a person during the acute febrile (viraemia) phase of
dengue illness. After an extrinsic incubation period of 8 to 10 days, the
mosquito becomes infected and virus is transmitted when the infective mosquito
bites and injects the saliva into the wound of the person . There is also evidence
of transovarian transmission.
Fig 1: Transmission cycle of dengue virus
IMMUNO-PATHOGENESIS
Primary or first infection in non-immune persons usually causes Dengue
fever. Subsequent dengue infection by different serotype causes more severe
illness  like  DHF/DSS.  The  key  manifestations  of  the  DHF/DSS  are  sudden
onset of shock, capillary leakage, haemorrhagic diathesis/ thrombocytopenia
occurring at the time of defervescence of fever. Pathogenesis is not well defined
but it is suggested that it is mediated through soluble mediators, compliment
activation and cytokines that are responsible for various manifestation.
CLINICAL MANIFESTATIONS OF DF/ DHF/DSS
Clinical manifestations vary from undifferentiated fever to florid
haemorrhage and shock. The clinical presentations depend on age, immune
status  of  the  host  and  the  virus  strain.  Under  NVBDCP  the  case  definitions
recommended by WHO are being followed, which is described below.
DENGUE FEVER: CLINICAL DESCRIPTION
An  acute  febrile  illness  of  2-7  days  duration  with  two  or  more  of  the
following manifestations:
Headache,
Retro-Orbital Pain,
Myalgia,
Arthralgia,
Rash,
Haemorrhagic Manifestations.
CRITERIA FOR DENGUE HAEMORRHAGIC FEVER AND DENGUE
SHOCK SYNDROME
DENGUE HAEMORRHAGIC FEVER :
A probable or confirmed case of dengue
plus
Haemorrhagic tendencies evidenced by one or more of the following
 1. Positive tourniquet test
2. Petechiae, ecchymoses or purpura
3. Bleeding from mucosa, gastrointestinal tract, injection sites or
other sites
4. Haematemesis or melena
Plus
Thrombocytopenia (<100,000 cells per cumm)
plus
Evidence of plasma leakage due to increased vascular permeability, manifested
by one or more of the following:
A rise in average haematocrit for age and sex > 20%
A more than 20% drop in haematocrit following volume replacement
treatment compared to baseline
Signs of plasma leakage (pleural effusion, ascites, hypoproteinaemia)
DENGUE SHOCK SYNDROME:
All the above criteria for DHF plus evidence of circulatory failure
manifested by rapid and weak pulse and narrow pulse pressure (<20 mm Hg) or
hypotension for age, cold and clammy skin and restlessness.
LABORATORY DIAGNOSIS OF DENGUE:
Laboratory diagnosis can be carried out by one or more of the following
tests:
Isolation of Dengue virus from serum, plasma, leucocytes or autopsy
samples.
Demonstration of a fourfold or greater rise in reciprocal IgG antibody
titres to one or more dengue virus antigen in paired sera samples.
Laboratory diagnosis of dengue depends on proper collection, processing,
storage and shipment of the specimens. While collecting blood for serological
studies from suspected DF/DHF cases all universal precautions should be taken.
Samples could be collected as soon as possible after the onset of illness,
hospital admission or attendance at a clinic (acute serum, S1).
Shortly before discharge from the hospital or, in the event of a fatality, at
the time of death (convalescent serum, S2).
In the event if hospital discharge occurs within 1-2 days of the subsidence
of fever collect a third specimen 7-21 days after the acute serum (S1) was drawn
(late convalescent serum, S3).
The optimal interval between the acute (S1) and the convalescent (S2 or
S3) serum is 10 days. The above recommendations allow for the collection of at
least two serum samples for comparison and ideally will provide for an
adequate interval between sera.   Serial (paired) specimens are required to
confirm or refute a diagnosis of acute flavivirus or dengue infection.
The dengue IgM antibody appears quite early in the course of illness. Its
detection requires only a single but properly timed blood sample. IgM responses
are also usually less cross-reactive to other flaviviruses. The procedure involved
is comparatively easier than other methods available for diagnosis of dengue
infections due to which   IgM Antibody Capture ELISA (MACELISA) is
currently followed for diagnosis of dengue infection in the network of sentinel
surveillance laboratories.
In a diagnosed case of dengue fever, the following laboratory values are
serially monitored to detect the capillary leak syndrome and other complications
early and thus avoid morbidity and mortality:
Platelet count
Haemoglobin
Haematocrit
White blood cell count
Liver function test
Renal function test
Urine routine examination.
ANATOMY OF LIVER: (20)
The liver is the largest abdominal organ and occupies the majority of the
upper right quadrant of the abdomen. The liver is encapsulated by a dense layer
of connective tissue, eponymously named Glisson’s capsule. Peritoneum covers
the liver except in the regions of the gall bladder fossa, the fossa for inferior
vena cava (IVC) and the bare area. The bare area abuts the diaphragmatic
surface posteriorly and is demarcated by the coronary ligament.
The porta hepatis is a transverse slit in the hilum of the liver that is
perforated by the right and left hepatic ducts, hepatic artery and portal vein. The
common bile duct, hepatic artery, portal vein, nerves of the liver and lymphatics
lie enclosed within the layers of hepatoduodenal ligament (20).
HEPATIC BLOOD SUPPLY
The liver has a dual blood supply from the hepatic artery (20%), which
provides systemic arterial circulation and the portal vein (80%) which returns
blood from the gastrointestinal tract and spleen. Factors that influences the
relative contribution of arterial and portal venous blood flow include hormonal,
autonomic neural and nutritional factors. The balance of blood supply may also
become dysregulated by hepatic parenchymal diseases(20).
PORTAL VEIN:
The portal vein arises from the confluence of the superior mesenteric and
splenic veins and is located posterior to the neck of the pancreas. The portal
vein courses superiorly and towards the right, just posterior to the common bile
duct and hepatic artery within the hepatoduodenal ligament (20).
At the porta hepatis, the portal vein divides into left and right branches.
The right branch courses horizontally and bifurcates into anterior and posterior
branches. The left branch is horizontal initially but then courses cranially and
terminates into ascending and descending branches. The left portal vein joins
the obliterated umbilical vein within the fissure of ligamentum teres hepatis.
Many anatomic variations of the portal vein exist. Most common is
absence of the right portal vein with anomalous branches from the main portal
vein and the left portal vein(20).
Fig 2: Formation of portal vein by the confluence of superior mesenteric
vein and splenic veins
HEPATIC ARTERY
The celiac axis divides into the common hepatic, splenic and left gastric
arteries at the level of T12-L1. After giving off the gastroduodenal artery, the
common hepatic artery becomes the proper hepatic artery, which ascends to the
liver, anterior to the portal vein and medial to the common bile duct.
 After entering the porta hepatis, the proper hepatic artery divides into the
right, left and occasionally middle hepatic arteries. The right and left hepatic
arteries supply the right and left lobes of the liver respectively. The right hepatic
artery also gives off the cystic artery to the gall bladder(20).
 .
HEPATIC VEINS
The right, middle and left hepatic veins lie within the posterosuperior
aspect of liver. The veins course through the liver superiorly and obliquely and
drain into the IVC. Several small emissary hepatic veins drain the caudate lobe
independently into the IVC(20).
PHYSIOLOGIC ANATOMY OF THE LIVER. (21)
The basic functional unit of the liver is the liver lobule which is a
cylindrical structure several millimetres in length and 0.8 to 2 millimetres in
diameter. The liver lobule is constructed around a central vein that empties into
the hepatic veins and then into the vena cava. The lobule itself is composed
principally of many liver cellular plates that radiate from the central vein like
spokes in a wheel. Each hepatic plate is usually two cells thick, and between the
adjacent cells lie small bile canaliculi that empty into bile ducts in the fibrous
septa separating the adjacent liver lobules.
 These septa have small portal venules that receive their blood mainly
from the venous outflow of the gastrointestinal tract by way of the portal vein.
From these venules blood flows into flat, branching hepatic sinusoids that lie
between the hepatic plates and then into the central vein. Thus, the hepatic cells
are exposed continuously to portal venous blood.
Hepatic arterioles are also present in the interlobular septa. These
arterioles supply arterial blood to the septal tissues between the adjacent
lobules, and many of the small arterioles also empty directly into the hepatic
sinusoids, most frequently emptying into those located about one third the
distance from the interlobular septa.
In  addition  to  the  hepatic  cells,  the  venous  sinusoids  are  lined  by  two
other types of cell: (1) typical endothelial cells and (2) large Kupffer cells (also
called reticuloendothelial cells), which are resident macrophages that line the
sinusoids and are capable of phagocytizing bacteria and other foreign matter in
the hepatic sinus blood.
Beneath endothelial lining of the sinusoids, narrow tissue spaces called
spaces of Disse, also known as the perisinusoidal spaces seen lying between the
endothelial cells and the hepatic cells connects with lymphatic vessels in the
interlobular septa.
Therefore, excess fluid in these spaces is removed through the
lymphatics. Because of the large pores in the endothelium, substances in the
plasma move freely into the spaces of Disse. Even large portions of the plasma
proteins diffuse freely into these spaces.
Fig 3: Sinusoidal anatomy of liver
PATHOPHYSIOLOGY OF CAPILLARY LEAK SYNDROME
Dengue viral infection of the liver affects the sinusoidal endothelial or
Kupffer cells causing obstruction to the hepatic sinusoidal capillary lumen  and
thus resulting in decreased portal venous blood velocity and flow to the
liver.when severe, shunting of portal blood away from the liver (hepatofugal
flow), dilated portal vein and increased congestive index. (22) This finding is
usually observed for patients with high resistance in the hepatic sinusoidal
capillary network, such as those with liver cirrhosis, hepatic sinusoidal
obstruction (hepatic veno-occlusive disease), arterioportal fistula,  and hepatic
venous outflow obstruction and is correlated with the degree of portal venous
hypertension. (23)  Of note are the similarities between clinical findings in
patients with Dengue viral infection and sinusoidal obstruction syndrome such
as hepatomegaly, ascites, right pleural effusion, swelling of the gall bladder
wall, and decreased velocity or reversed direction of portal blood flow. (24)
This is also proved by the liver autopsy specimens of terminal DSS
patients generally showing massive or focal necrosis with little or no
recruitment of polymorphonuclear cells or lymphocytes. (25, 26)
Chart 1: Flow chart describing the pathophysiology of dengue in liver
Fernando  et  al described the varying degrees of liver involvement in
acute dengue infection and postulated the causes to be hepatocyte apoptosis
directly by virus , hypoxic injury due to impaired liver perfusion , oxidative
stress or immune mediated injury.(27)
Because portal venous blood comprises 75% of total hepatic blood, this
condition coupled with decreased hepatic arterial blood flow as a consequence
of shock leads to severe and irreversible liver damage.
In  a  study  by Wahid  SF,  Sanusi  S,  Zawawi  MM,  et  al titled  “A
comparison of the pattern of liver involvement in dengue hemorrhagic fever
with classic dengue fever” in 2000 , indicated that the degree of liver
impairement was related to the severity of dengue hemorrhagic fever and
concluded that hepatomegaly and liver dysfunction were commoner in DHF
than in DF.(28)
SONOGRAPHIC TECHNIQUE (29)
PRE- IMAGING INSTRUCTIONS:
 The patients are instructed to avoid food and drinks known to produce gas
such as carbonated drinks, beer and dairy products, for 24 hours before the scan.
 The patient is advised to be on fasting with nothing more than small
amounts of clear fluid for 8 hours before the scan.
 The B-mode examination included a general abdominal survey with
evaluation of the size and architecture of liver, gall bladder, spleen, peritoneal
cavity and chest wall.
ASSESSMENT OF LIVER : (29)
The liver is best examined with real-time sonography, ideally after a 6-
housr fast. Both supine and right anterior oblique views should be obtained.
Sagittal, transverse, coronal, and subcostal oblique views are suggested using
both a standard abdominal transducer and a higher frequency transducer. Many
patients’ liver is tucked beneath the lower right ribs, so a transducer with a
small scanning face, allowing an intercostal approach, is invaluable.
Fig 4 -USG Parasagittal Scan Plane shows liver and right kidney
Fig 5- USG intercostal scan plane Shows The Middle and Rt Hepatic
Vein
Fig 6 - USG Subcostal plane view with the probe is angled
cephalad under the ribs to avoid any bowel or ribs shadowing over
the Liver shows the Right lobe of liver with Right Portal vein
Fig 7 - Scan plane for left lobe of liver -The probe is in the epigastric
region just below the sternum and angled cephalad to view the left
lobe entirely and angled towards the left side to see the most medial
edge of the left lobe
ASSESSMENT OF GB 29
Evaluation of the gallbladder is usually performed with routine sagittal
and transverse sonograms. If the gallbladder is not visualized, however,
manoeuvres to evaluate the gallbladder fossa are essential to avoid missing
gallbladder pathology. This is done primarily with subcostal oblique sonograms,
performed with the left edge of the transducer more cephalad than the right
edge. The face of the transducer is directed toward the right shoulder.
Ingestion of food, particularly fatty food, stimulates the gallbladder to
contract. The contracted gallbladder appears thick walled and may obscure
luminal or wall abnormalities. Therefore, the examination of the gall bladder
should be performed after a minimum of 4 hours of fasting.
Fig 8 - USG Left lateral decubitus view shows normal
visualisation of GB
ASSESSMENT OF SPLEEN 29:
 The most common and easy approach to visualize the spleen is to
maintain the patient in the supine position and place the transducer in the
coronal plane of section posteriorly in one of the lower left intercostal spaces.
The patient can then be examined in various degrees of inspiration to maximize
the window to the spleen. An oblique plane of section along the intercostal
space can avoid rib shadowing.  A transverse plane from a lateral, usually
intercostal, approach may help to localize a lesion within the spleen anteriorly
or posteriorly.
Fig 9 - USG intercostal plane view with Patient in right lateral
decubitus position shows normal appearance of spleen
ASSESSMENT OF CHEST WALL: (30)
A curvilinear probe allows visualization of the deeper structures, and the
sector scan field allows a wider field of view through a small acoustic window.
The chest wall, pleura, and lungs may be quickly surveyed with the curvilinear
probe. A high-resolution 7.5–10-MHz linear probe can be used to provide
detailed depiction of any chest wall, pleural, or peripheral lung abnormality.
The transducer should be centered between the ribs and held perpendicular to
the skin. Echo-free pleural fluid can be recognized above the diaphragm, lying
in the pleural space. The lung will be highly echogenic because of the contained
air.
Raising the arm above the patient's head increases the rib space distance
and facilitates scanning with the patient in erect or recumbent positions. The
posterior chest is best imaged with the patient sitting upright, while the anterior
and lateral chest may be assessed in the lateral decubitus position
Fig 10 - Scanning positions for chest US. (a) The posterior chest is
best scanned with the patient in the sitting positon. (b) The anterior
and lateral chest can be examined with the patient in the lateral
debcubitus position.
Fig 11 - Normal US appearance of the chest. Below the relatively
echogenic subcutaneous tissue, the intercostal muscles appear
hypoechoic but contain multiple echogenic fascia planes. The pleural
interface appears as an echogenic line. The sharp change in the
acoustic impedance at this interface results in reverberation artifacts
(*), appearing as a series of horizontal lines parallel to the pleural
interface. Vertical comet tail artifacts (+) can also be seen.
a. A large anechoic effusion with passive atelectasis of the underlying
lung is seen.
Fig 12 - Sites of duplex insonation of splanchnic venous system
in patients examined for possible portal hypertension.
ASSESSMENT OF PORTAL VEIN: (31)
The portal vein is the most readily accessible vessel in the portal system.
The entire length of the portal vein was examined from an anterior abdominal,
subcostal approach, using a right paramedian, slightly oblique plane or left
lateral decubitus position.Depending on vessel orientation and body habitus, the
portal vein and hepatic artery are best interrogated by either a subcostal
approach pointing posterocephalad, or a right intercostal approach pointing
medially. Since the portal vein and hepatic artery travel together in the portal
triad, along with the common duct, these approaches should satisfactorily
interrogate both vessels.
Whenever possible, the portal vein was examined as it crosses the hepatic
artery. At this point, the portal venous signal was easily obtained and the
direction of flow could be compared with that of the hepatic artery. Flow
direction in all portal vein branches was recorded using an intercostal or
subcostal, transverse or oblique approach.
GREY SCALE:
The following were determined:
Presence or absence of the vessel image on real-time imaging
Presence or absence of intraluminal echogenic material
Vessel diameter
Cross sectional area.
Fig 13 - Grey scale USG subcostal right paramedian approach showed,
portal vein diameter measured at the level of hilum 15.7 mm
Fig 14 - Spectral Colour doppler image showed normal portal vein flow
and  colour uptake with normal hepatopetal flow pattern and normal
respiratory variation and The flow velocity is 15.2 cm/sec
Fig 15 - Grey scale sonogram showed measurement of cross-
sectional area 1.37 cm2
Fig 18 - US scan at the level of porta hepatis showing the portal vein
and the collapsed common duct (arrow) anterior to it. The circular
structure anterior to the portal vein is the hepatic artery seen in cross
section (arrowhead)
Fig 16 -Portal best seen with a subcostal oblique view, the main
portal vein is formed by the union of the right and left portal venous
branches at the porta hepatis.
Fig 17 - Segmental branches of the right and left portal veins are
marked. Well seen is the recumbent-H shape of the left portal venous
bifurcation, made from the ascending and horizontal left portal vein
and the segmental branches to 2, 3, and 4.

Fig 19 - Oblique colour Doppler image of the porta hepatis. The
hepatic artery (HA) accompanies the portal vein (PV) and bile ducts.
With the colour scale appropriately set for the slow flow within the
portal vein, hepatic arterial flow projects as colour aliasing.
Fig 20 -Spectral Doppler tracing of normal portal vein flow. The flow
velocity of 20 cm/s is relatively uniform and in a hepatopetal
direction.
PORTAL VENOUS DOPPLER STUDY
The following were determined:
Colour uptake
Direction of Flow – Hepatopetal / Hepatofugal
Velocity of flow
Flow volume
AIM
? To evaluate the ultrasonographic features of capillary leak syndrome in
dengue fever patients.
? To investigate the role of Doppler study of the portal vein as a predictor
for capillary leakage in dengue fever serology  positive patients.
? To compare and correlate the portal venous Doppler findings with the
laboratory findings and clinical outcome.
MATERIALS AND METHODS
SOURCE OF DATA:
The prospective study was performed in the Department of
Radiodiagnosis, Govt. Kilpauk Medical College Hospital, Kilpauk, Chennai, on
patients with dengue fever.
STUDY DESIGN:
             Prospective Cohort Study
STUDY POPULATION:
             Patients with Acute fever, clinical symptoms and signs of dengue with
laboratory evidence of thrombocytopenia, NS1 and IGM Positivity
STUDY PERIOD:
              From March 2018 to September 2018 , for a period of 7 months
SAMPLE SIZE :
              100
STUDY CENTRE:
              Department of Radiodiagnosis, Govt. Kilpauk Medical College
Hospital, Kilpauk, Chennai.
SAMPLING TECHNIQUE: Convenience Sampling.
INCLUSION CRITERIA:
? Acute Fever patients with thrombocytopenia and with
? IGM positive
? NS1 positive
EXCLUSION CRITERIA:
? Patient with Chronic liver disease / tumours.
? Known case of Hypoalbuminemia
? Known case of Hypotension
? MP/Mf positive
? Known case of portal vein / splanchnic vessel thrombosis.
? Patients who don’t give consent for the study.
METHOD OF COLLECTION OF DATA:
A structured pre-prepared case proforma was used to enter the patient
details, clinical history and serological status of patients who met the inclusion
criteria. Ultrasonography was performed as an initial imaging examination,
followed by portal venous Doppler and the findings were recorded.
 METHODOLOGY
STUDY TECHNIQUE
? The study was started after obtaining institutional ethical committee
clearance. All the included cases were subjected to imaging after
obtaining written consent.
? Ultrasonography of the abdomen and chest wall was performed in real
time, in grey scale and color Doppler modes, using 3.5- 5 MHz convex
curvilinear probe in GE –LOGIQ S7, SONOSCAPE, ESOATE MY LAB
40 and SAMSUNG machines at the time of admission.
? The patient was usually scanned in 4 -6 hours fasting, in supine or left
decubitus position.
? General examination of the liver was done to rule out chronic liver
pathologies.
? Check was made of sonographic features like
? Gall bladder wall edema
? Gall bladder wall thickness
? Ascites
? Pleural effusion
? Splenomegaly.
PORTAL DOPPLER STUDY:
? The portal vein was interrogated either in subcostal approach pointing
posterocephalad or in right intercostal approach pointing medially.
? Grey scale assessment of portal vein was done and the following were
recorded:
?  Portal vein diameter
? Cross sectional area.
? Colour  and  spectral  Doppler  assessment  of  portal  vein  is  done  with
appropriate machine settings to evaluate the following:
? Flow velocity
? Flow direction
? Congestive Index is then calculated with the formula:
                  Cross sectional area (cm2) / portal venous velocity (cm/sec).
ASSESSMENT
? The ultrasonographic features and Doppler findings were then correlated
with Clinical outcome and laboratory findings.
CASE 1
? 23-year-old male patient presenting with complaints of high-grade fever
for 3 days, retroorbital pain and abdominal pain with melena.
? Laboratory investigations showed thrombocytopenia with platelet count
44000.
? Portal venous doppler was done at the time of admission
Fig 21 - Grey scale USG subcostal right paramedian approach showed, portal
vein diameter measured at the level of hilum - 11.1 mm
Fig 22 - Right subcostal oblique sonogram showed increased GB wall thickness
measures 10.4 mm   which is measured along the liver parenchyma
Fig 23 - Spectral Colour doppler image showed normal portal vein flow.portal
vein colour uptake appeared normal with normal hepatopetal flow pattern and
normal respiratory variation and the flow velocity is 15.2 cm/sec
Fig 24 - Grey scale sonogram showed measurement of cross-sectional area 1.37
cm2
On follow up, The patient developed CLS and laboratory investigations
showed elevated Hb and haematocrit values
Fig 25 - Grey scale USG image showed free fluid in peritoneal cavity
Fig 26 - Oblique left lower rib intercostal view showed normal splenic
echotexture, appears normal in size measuring 11.5cm
CASE 2
? A 45-year-old female complaints of fever with chills for 5 days Nausea,
Vomiting and Abdominal pain
? Lab investigations showed platelet count 64000, IGM positive.
? Portal venous doppler was done at the time of admission
Fig 27 - USG abdomen showed portal vein diameter measuring 10.9 mm
Fig 28 - GB wall thickening measured 5.8 mm
Fig 29 - PV Doppler showed normal colour uptake ,hepatopetal flow and
velocity measured 13.86 cm/sec
Fig 30 - Cross sectional area measured 1.28 cm2
 On follow up, the patient developed CLS and laboratory investigations
showed elevated Hb and haematocrit values
Fig 31 - USG Chest showed minimal fluid collection noted in right
pleural cavity
Fig 32 - USG Abdomen showed minimal fluid collection noted in
hepatorenal pouch
Fig 33 - Oblique sonogram of abdomen left lower rib intercostal
view showed normal splenic echotexture and size
CASE 3
? A 31 year old female came with complaints of  high grade fever for 3
days Nausea Vomiting ,Abdominal pain and
? Lab investigations showed Platelet count 64000,NS 1 positive
? PV Doppler done at the time of admission
Fig 34 ,35 - PV Doppler image showed portal vein diameter measured
10.3 mm, normal colour uptake and respiratory variation heoatopetal
flow with velocity measured 25.65 cm/sec.
Fig 36 - USG Abdomen Grey scale image showed cross sectional area
measuring 1.37 cm2
Fig 37 - GB wall thickness appeared normal measured 1.2 mm.
 On follow up, the patient didn’t develop CLS and laboratory
investigations showed normal Hb and haematocrit values
Fig 38,39 - USG Abdomen showed No Ascites and No Pleural effusion
Fig 40 - USG Abdomen showed normal splenic echotexture and
measurement
CASE 4
? A 27-year-old male came with complaints of fever for 5 days Nausea,
Vomiting and abdominal pain.
? Lab investigations showed thrombocytopenia with platelet count 41000,
IGM positive
? PV Doppler done at the time of admission showe
Fig 41 - Grey scale image showed Portal vein diameter measured 14.8 mm
Fig 42 - Portal vein doppler showed normal hepatopetal flow and normal
respiratory variation with normal velocity measured 30.5 cm/sec
Fig 43 - Grey scale image showed cross sectional area measured 1.28 cm2
Fig 44 - USG Abdomen showed normal GB wall thickness measured 1.6 mm
On follow up, the patient didn’t develop CLS and laboratory
investigations showed normal Hb and haematocrit values
Fig 45&46 - USG Abdomen showed absence of Ascites and Pleural
Effusion
Fig  47 - USG abdomen showed normal splenic echotexture and
measurement
CASE 5
? A 18 year old Female came with complaints of low grade intermittent
fever for 7 days Nausea, Vomiting and abdominal pain.
? Lab investigations showed thrombocytopenia with platelet count 32000
and IGM positive
? PV Doppler done at the time of admission showed
Fig 48 - Grey scale sonographic image showed portal vein measures 13.8
mm.
Fig 49 - PV doppler showed normal hepatopetal flow and normal
respiratory variation with normal velocity measured 17.33 cm/sec.
Fig 50 - Grey scale image showed ,cross sectional area measured 1.17 cm2
Fig 51 - USG Abdomen showed normal GB wall thickness  measured 2.9
mm
On follow up, the patient developed CLS and laboratory investigations
showed elevated Hb and haematocrit values
Fig 52 - USG Abdomen showed normal splenic echotexture and
measured 11.5 cm.
CASE 6
? A 37-year-old Male came with complaints of High-grade intermittent
fever for 5 days nausea, Vomiting and abdominal pain.
? Lab investigations showed thrombocytopenia with platelet count 34000
and IGM positive
? PV Doppler done at the time of admission showed
Fig 53 - Grey scale sonographic image showed portal vein diameter  measured 9.6
mm.
Fig 54 - Portal vein doppler showed normal hepatopetal flow and normal
respiratory variation with normal velocity measured 32.5 cm/sec.
Fig 55 - Grey scale image showed ,cross sectional area measured 0.71 cm2
Fig 56 - USG Abdomen showed normal GB wall thickness  measured 1.7 mm
On follow up, the patient didn’t develop CLS and laboratory
investigations showed normal Hb and haematocrit values
Fig 57 - USG Abdomen showed absence of  Ascites  and  Pleural effusion
Fig 58 - USG Abdomen showed normal splenic echotexture and  measured
8.6 cm.
CASE 7
? A 29-year-old Female came with complaints of High-grade intermittent
fever for 6 days nausea, Vomiting, abdominal pain and Rashes.
? Lab investigations showed thrombocytopenia with platelet count 71000
and IGM positive
? PV Doppler done at the time of admission showed
Fig 59 - Grey scale sonographic image showed portal vein diameter
measured 15.7 mm.
Fig 60 - Portal vein doppler showed normal respiratory variation with
velocity measured 7.32 cm/sec.
Fig 61- Grey scale image showed ,cross sectional area measured 1.74 cm2
Fig 62 - USG Abdomen showed increased GB wall thickness measured 8.2 mm
On follow up, the patient developed CLS and laboratory investigations
showed elevated Hb and haematocrit values
Fig 63- USG Abdomen Showed minimal Ascites  And   No Pleural Effusion
Fig 64 - USG Abdomen showed normal splenic echotexture and measured
12.1 cm
STATISTICAL ANALYSIS
The Data was entered in a excel worksheet and double checked. Both
descriptive and inferential statistics were employed for data analysis.
IBM SPSS version 22 software was used for statistical analysis.
DESCRIPTIVE STATISTICS:
The descriptive statistics procedure displayed uni-variate summary
statistics for several variables in a single table and calculated standardized
values. Variables were ordered by the size of their mean, alphabetically, in
ascending or descending order or in any other suitable order. Descriptive
analysis was carried out using mean and standard deviation for quantitative
variables.
 In the present study following descriptive statistics have been employed
? Frequencies
? Percentages
The frequencies procedure provides statistics and graphical displays that are
useful for describing many types of variables.
Data was also represented using appropriate diagrams like bar diagram,
pie diagram and box plots. For a frequency report and bar chart, the categories
were arranged in order, by their frequencies.
CROSSTABS:
Using the crosstabs procedures, two-way and multiway tables were
formed and   measures of association were determined for two-way tables.
The sensitivity, specificity, positive and negative predictive values and
diagnostic accuracy of Portal venous doppler in predicting the development of
the capillary leak syndrome in dengue fever patients, correlated and confirmed
with clinical findings and laboratory investigations along with their 95% CI
(Confidence Interval) were computed and presented. Reliability of the test was
assessed by kappa statistics along with its 95% CI and P Value.
P value < 0.05 was considered statistically significant.
RESULTS
Hundred patients, who were referred to the Department of
Radiodiagnosis, Govt. Kilpauk Medical College Hospital, Kilpauk, Chennai,
during the study period, with complaints of acute fever, clinical symptoms and
signs of dengue with laboratory evidence of thrombocytopenia, NS1 and IGM
Positivity and who satisfied the inclusion and exclusion criteria of the study
were included in the study.
Ultrasonography and portal venous Doppler study was performed and the
findings were recorded.
Table 1 : Descriptive analysis for age  in study population (N= 100)
Age Group CLS Total
Positive Negative
10 – 20 Count % 25
27.8%
3
30.0%
28
28%
21 – 30 Count % 32
35.6%
5
50%
37
37%
31 -40 Count % 24
26.7%
1
10%
25
25%
41 – 50 Count % 7
7.8%
1
10%
8
8%
>50 Count % 2
2.2%
0
0%
2
2%
Total Count
%
90
100%
10
100%
100
100.0%
The most common age group included in this study was 21-30yrs. 32 out
of the 37 in this age group developed Capillary leak syndrome.
Chart 2: Distribution of Age in the study population
Chart 3: Distribution of Age group in CLS Positive patients
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Chart 4: Distribution of Age group in CLS Negative patients
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Table 2 : Descriptive analysis for sex in study population (N= 100)
Sex CLS Total
Positive Negative
Female Count % 52
57.8%
8
80.0%
60
60.0%
Male Count % 38
42.2%
2
20.0%
40
40.0%
Total Count % 90
100%
10
100.0%
100
100.0%
60 female patients  and 40 male patients  were included in the study.  Out
of the 60 female patients, 52 developed capillary leak syndrome, while 8 were
in the non-CLS group. 38 male patients developed CLS and 2 did not.
Chart 5 : Sex  Distribution of CLS in study population (N= 100)
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Table 3 :  Descriptive analysis for  GB wall edema  in study population
GB wall Edema
CLS
Total PPositive Negative
Present Count % 54
60.0%
1
10.0%
55
55.0%
0.003Absent Count % 36
40.0%
9
90.0%
45
45.0%
Total Count % 90
100%
10
100.0%
100
100.0%
55 patients in the study had GB wall edema while 45 patients had normal
gall bladder appearance. 54 (98.1%) out of the 55 patients developed CLS and
1(1.9%) did not and so the specificity was 90% and positive predictive value
was 98.1%.  But, 36 of the 45 patients with normal gall bladder appearance
developed CLS, thus the negative predictive value was 20%.
Chart 6: Distribution of GB wall edema in study population (N= 100)
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Table 4 : Descriptive analysis for   Ascites  in study population
(N= 100)
Ascites
CLS
Total pPositive Negative
Present Count % 33
36.7%
0
0%
33
33.0%
0.019Absent Count % 57
63.3%
10
100.0%%
67
67.0%
Total Count % 90
100%
10
100.0%
100
100.0%
 33  patients  (36.7%)  of  the  study  sample  showed  ascites  and  all  these
patients developed CLS. None of the non -CLS patients showed ascites while
63.3% were false negative revealing that though the negative predictive value
was less and  positive predictive value was 100%.
Chart 7 : Distribution of Ascites in study population (N= 100)
Table 5 : Descriptive analysis for  pleural effusion  in study population
Pleural effusion
CLS
Total PPositive Negative
Present Count % 44
48.9%
0
0%
44
44%
0.003Absent Count % 46
51.1%
10
100.0%%
56%
45.0%
Total Count % 90
100%
10
100.0%
100
100.0%
Pleural  effusion  was  seen  in  44%  of  study  patients  and  these  patients
developed CLS. None of the non CLS patients showed pleural effusion. But >
50% of CLS patients did not develop pleural effusion and hence the sensitivity
was 36.6% and negative predictive value was 15%.
Chart 8 : Distribution of pleural effusion in study population
(N= 100)
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Table 6 : Evaluation of GB wall thickness in the study population
CLS N Mean
Std.
Deviation
Std. Error
Mean
GB wall
thickness [mm]
POSITIVE 90 3.973 2.4644 .2598
NEGATIVE 10 2.110 .5446 .1722
A mean value of 3.973   was found in the patients who developed CLS
while the non CLS patients had a mean value of 2.110.
Chart 9 :  ROC curve for GB wall thickness in study population
(N= 100)
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Table 7 : Analysis of  ROC curve for  GB wall thickness in study
population (N= 100)
Area under the ROC curve (AUC) 0.745
Standard Errora 0.0551
95% Confidence intervalb 0.648 to 0.827
z statistic 4.445
Significance level P (Area=0.5) <0.0001
Youden index J 0.5667
Area under the ROC curve was 0.745 with a standard error of 0.0551 and
95% confidence interval of 0.648 to 0.827. With an optimal criterion of >3mm,
the sensitivity was 56.7%   while specificity reached to 100%
Table 8 : Evaluation of PV Diameter in the study population
CLS N Mean
Std.
Deviation
Std. Error
Mean
PV
Diameter
POSITIVE 90 12.884 1.9047 .2008
NEGATIVE 10 11.310 2.0047 .6339
     A mean value of 12.884  was found in the patients who developed CLS
while the non CLS patients had a mean value of 11.310.
Chart 10 :  ROC curve for PV Diameter in study population (N= 100)
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Table 9 : Analysis of  ROC curve for  PV Diameter in study population (N=
100)
Area under the ROC curve (AUC) 0.729
Standard Errora 0.0989
95% Confidence intervalb 0.631 to 0.813
z statistic 2.314
Significance level P (Area=0.5) 0.0207
Youden index J 0.4556
Area under the ROC curve was 0.729 with a standard error of 0.0989 and
95% confidence interval of 0.631 to 0.813. With a criterion of >11.2mm, the
sensitivity was 75.6%   while specificity was 70%
Table 10 : Evaluation of PV Velocity[cm/sec] in the study population
CLS N Mean
Std.
Deviation
Std. Error
Mean
PV Velocity
[cm/sec]
POSITIVE 90 18.27 5.274 .556
NEGATIVE 10 25.10 6.315 1.997
A mean value of 18.27  was found in the patients who developed CLS
while the non CLS patients had a mean value of 25.10.
Chart 11 :  ROC curve for PV Velocity[cm/sec] in study population (N=
100)
Table 11: Analysis of ROC curve for PV Velocity[cm/sec] in study
population (N= 100)
Area under the ROC curve (AUC) 0.781
Standard Errora 0.0863
95% Confidence intervalb 0.687 to 0.857
z statistic 3.250
Significance level P (Area=0.5) 0.0012
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 Area under the ROC curve was 0.781 with a standard error of 0.0863 and
95% confidence interval of 0.687 to 0.857. With a criterion of <25cm/sec, the
sensitivity was 93.3%   while specificity was 60%.
Table 12 : Evaluation of Cross sectional area[Cm2] in the study population
CLS N Mean
Std.
Deviation
Std. Error
Mean
Cross
sectional
area[Cm2]
POSITIVE 90 1.4748 .45682 .04815
NEGATIVE 10 1.1340 .26892 .08504
A mean value of 1.478  was found in the patients who developed CLS
while the non CLS patients had a mean value of 1.1340.
Chart 12 :  ROC curve for Cross sectional area[Cm2] in study population
Table 13 : Analysis of  ROC curve for  Cross sectional area[Cm2] in study
population (N= 100)
Area under the ROC curve (AUC) 0.718
Standard Errora 0.0744
95% Confidence intervalb 0.619 to 0.803
z statistic 2.927
Significance level P (Area=0.5) 0.0034
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Area under the ROC curve was 0.718 with a standard error of 0.0744  and
95% confidence interval of 0.619 to 0.803 . With a criterion of >1.25 cm2 the
sensitivity was 61.1%   while specificity was 80%.
Table 14 : Evaluation of Congestion index in the study population
CLS N Mean
Std.
Deviation
Std.
Error
Mean
Congestion
index
POSITIVE 90 .09724518537179 .0847019771873 .04815
NEGATIVE 10 .04770130927474 .0161621678013 .08504
A mean value of 0.09724   was found in the patients who developed CLS
while the non CLS patients had a mean value of 0.04770
Chart 13 :  ROC curve for Congestion index in study population
(N= 100)
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Table 15 : Analysis of  ROC curve for  Congestion index in study
population (N= 100)
Area under the ROC curve (AUC)  0.827
Standard Errora 0.0633
95% Confidence intervalb 0.738 to 0.895
z statistic 5.164
Significance level P (Area=0.5) <0.0001
Youden index J 0.5556
Area under the ROC curve was 0.827 with a standard error of 0.0633  and
95% confidence interval of 0.738 to 0.895 . With a criterion of >0.0706  the
sensitivity was 55.6%   while specificity was 100%.
Table 16 : Evaluation of Platelet count in the study population
CLS N Mean
Std.
Deviation
Std. Error
Mean
Platelet
count
POSITIVE 90 49900.00 34329.222 3618.618
NEGATIVE 10 96040.00 64713.852 20464.317
A mean value of 49900  was found in the patients who developed CLS while
the non CLS patients had a mean value of  96040.
Chart 14  :  ROC curve for Platelet count in study population
(N= 100)
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Table 17 : Analysis of  ROC curve for  Platelet count in study population
(N= 100)
Area under the ROC curve (AUC) 0.746
Standard Errora 0.0937
95% Confidence intervalb 0.649 to 0.827
z statistic 2.622
Significance level P (Area=0.5) 0.0088
Youden index J 0.5222
Area under the ROC curve was 0.746  with a standard error of 0.0937
and 95% confidence interval of 0.649 to 0.827 . With a criterion of  <50000  the
sensitivity was 62.2%   while specificity was 90%.
Table 18 : Evaluation of Hematocrit in the study population
CLS N Mean
Std.
Deviation
Std. Error
Mean
Haematocrit
PCV
POSITIVE 90 36.778 6.2842 .6624
NEGATIVE 10 34.100 2.6796 .8473
A mean value of 36.778  was found in the patients who developed CLS
while the non CLS patients had a mean value of 34.100.
Chart 15 :  ROC curve for Hematocrit in study population (N= 100)
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Table19 : Analysis of  ROC curve for  Hematocrit in study population (N=
100)
Area under the ROC curve (AUC) 0.666
Standard Errora 0.0644
95% Confidence intervalb 0.565 to 0.757
z statistic 2.581
Significance level P (Area=0.5) 0.0099
Youden index J 0.4333
Area under the ROC curve was 0.666 with a standard error of 0.0644  and
95% confidence interval of 0.565 to 0.757 With a criterion of  >37.4  the
sensitivity was 43.3%   while specificity was 100%.
Table 20 : Evaluation of Hemoglobin in the study population
CLS N Mean
Std.
Deviation
Std. Error
Mean
Hb% POSITIVE 90 12.317 2.0239 .2133
NEGATIVE 10 11.400 .6218 .1966
A mean value of 12.317   was found in the patients who developed CLS
while the non CLS patients had a mean value of 11.400.
Chart 16  :  ROC curve for Hemoglobin in study population (N= 100)
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Table 21 : Analysis of  ROC curve for  Hemoglobin in study population
(N= 100)
Area under the ROC curve (AUC) 0.667
Standard Errora 0.0550
95% Confidence intervalb 0.566 to 0.758
z statistic 3.042
Significance level P (Area=0.5) 0.0023
Youden index J 0.4667
Area under the ROC curve was 0.667 with a standard error of 0.0550  and
95% confidence interval of 0.566 to 0.758 , With a criterion of  >12.5  the
sensitivity was 46.7%   while specificity was 100%.
Table 22 : Accuracy of ultrasonographic features with respect to clinical
outcome
Reliability Ultrasonographic Features
GB wall edema Ascites Pleural Effusion
Sensitivity (%) 60 36.6 48.9
Specificity (%) 90 100 100
PPV (%) 98.1 100 100
NPV (%) 20 15 17.8
Diagnostic
Accuracy (%)
63 43 54
All the ultrasonographic features had a high specificity and positive
predictive value. Since the false negative frequencies were high , the features
showed a less negative predictive value and the diagnostic accuracies yielded
were 63%,43%,and 54% for GB wall edema, ascites and pleural effusion .
Table 23 :Accuracy of Portal Venous Doppler features with respect to
clinical outcome
Reliability Portal Venous Doppler Features
PV
Diameter
PV Velocity Cross
Sectional
Area
Congestive
Index
Sensitivity (%) 75.6 93.3 61.1 55.6
Specificity (%) 70 60 80 100
PV Velocity had an increased sensitivity than other features, while
congestive index showed 100% specificity.
Table 24 :  Significance of Portal Venous Doppler features with respect to
clinical outcome by binary logistics
PV Doppler Features Significance
PV Diameter(cm) .494
PV Velocity (cm/ sec) .004
Cross sectional area (Cm2) .296
PV Velocity had the maximum significance among all the portal vein
Doppler indices
Table 25 : Comparison of the ultrasound and Doppler features with respect
to clinical outcome
Features Sensitivity
(%)
Specificity (%)
Ultrasonongraphic features
GB wall edema 60 90
Ascites 36.6 100
Pleural Effusion 48.9 100
Portal Doppler features
PV Diameter 75.6 70
PV Velocity 93.3 60
Cross Sectional Area 61.1 80
Congestive Index 55.6 100
Ultrasonographic features had an increased  specificity , but low
sensitivity. In comparison with the indices of ultrasonographic features, portal
Doppler features showed increase in sensitivity, thus revealing the reduction in
false negative rate.
Chart 17 :  Comparison of ROC curves
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Table 26  : Comparative  Analysis of  ROC curve for  Portal Venous Doppler
features and laboratory findings  in study population (N= 100)
Features Criterion  Sensitivity Specificity  AUC SE 95% CI
Ultrasonongraphic features
GB edema >3 56.7 100 0.745 0.0551 0.648 to 0.827
Ascites - 36.6 100 - - -
Pleural
effusion
- 48.9 100 - - -
Portal Doppler features
PV Velocity
cm/sec
  <25 93.3 60.0 0.781 0.0863 0.687 to 0.857
PV Diameter >11.2 75.6 70.0 0.729 0.0989 0.631 to 0.813
Cross sectional
area Cm2
>1.25 61.1 80.0 0.718 0.0744 0.619 to 0.803
Congestion
index
>0.0706 55.6 100 0.827 0.0633 0.738 to 0.895
Laboratory findings
Platelet count <50000 62.2 90.0 0.746 0.0937 0.649 to 0.827
Hematocrit/
PCV
>37.4 43.3 100 0.666 0.0644 0.565 to 0.757
Hemaglobin >12.5 46.7 100 0.667 0.0550 0.566 to 0.758
The area under ROC curve of congestive index is the highest (0.827) with
least standard error(0.0633), indicated its increased reliability in comparison
with other Doppler features.
       Thus the diagnostic accuracy would increase when the ultrasonography is
combined with portal venous Doppler to predict the Capillary leak syndrome in
dengue fever patients.
DISCUSSION
Dengue fever (DF) and its severe forms—dengue haemorrhagic fever
(DHF) and dengue shock syndrome (DSS)—have become major international
public health concerns. Over the past three decades, there has been a dramatic
global increase in the frequency of dengue fever (DF), DHF and DSS and their
epidemics, with a concomitant increase in disease incidence. The increase of DF
is due to uncontrolled population growth and urbanization in the absence of
appropriate water management, global spread of dengue strains via travel and
trade, and erosion of vector control programs.
Due to molecular mimicry between dengue virus and platelet, the dengue
antibody affects the platelet and destroy them. It also affect other cells like
WBC, RBC. The destructed platelets releases cytokines and other chemical
mediator which act on vascular endothelium & increases vascular permeability
leading to Capillary leak syndrome. (32)  So,  it  is  suggestive  that  all  the
complication of dengue is due to platelet destruction and hence the severity of
dengue fever depends on the degree of platelet destruction.
Plasma leakage, hemoconcentration, and abnormalities in hemostasis
characterize severe dengue. Hemorrhage may be a consequence of the
thrombocytopenia and associated platelet dysfunction or disseminated
intravascular coagulation.(33)
 In this study, out of the 100 serologically dengue fever positive patients
included, follow up clinical outcome revealed that 90 patients developed
capillary leak syndrome and 10 patients did not develop. 6 out of the 90
capillary leak syndrome patients went in for coagulopathy and had bleeding
manifestations.
The majority of the study population belonged to the 21-30yrs age group.
Maximum number of patients who developed CLS belonged to this age group.
Since the study was undertaken in a general hospital, not much of pediatric
patients were included in the study.
In this study, 60 female patients and 40 male patients were included. 52
out of the 60 female patients and 38 out of the 40 male patients developed CLS.
57.8% of 90 patients who developed CLS   were females while 42.2% were
males.  The  distribution  of  sex  did  not  show  any  statistical  significance  as  a
greater number of female patients were included in the study than the male
patients and this was purely co-incidental.
ULTRASONOGRAPHIC FEATURES
Capillary leak syndrome / plasma leak is clinically evident by the
accumulation of free fluid in the visceral spaces manifested by ascites, pleural
effusion, pararenal and perirenal fluid collections, hepatic and splenic
subcapsular fluid collections, pericardial effusion, and also causes
hepatomegaly, splenomegaly, and pancreatic gland enlargement.
Ultrasonographic features of GB wall edema and thickness, ascites and pleural
effusion were predominantly assessed in this study, as these were the most
commonly associated features in dengue fever.
 55 patients in the study had GB wall edema while 45 patients had normal
gall bladder appearance. 54 (98.1%) out of the 55 patients developed CLS and
1(1.9%) did not and so the specificity was 90% and positive predictive value
was 98.1%.  But, 36 of the 45 patients with normal gall bladder appearance
developed CLS, thus the negative predictive value was 20%.
The  mean  value  of  Gall  Bladder  wall  thickness  in  the  patients  who
developed CLS was found to be 3.973, while the mean value in the patients who
did not develop CLS was 2.110 in our study. Using the ROC curve, an optimal
criterion of  > 3mm was formulated, and the sensitivity was found to be 56.7%
while specificity reached to 100%. This correlated well with the study by
Setiawan  MW  ,  et, where , the sonographic finding of GBWT > 3 mm to 5
mm, with 93.8% sensitivity, was  used as a criterion indicating the need for
admission and monitoring and GBWT of > or = 5 mm, with 91.7% specificity,
was useful as a criterion for identifying DHF patients at high risk of developing
hypovolemic shock.(34)
In  another  study  by Quiroz-Moreno, et al, (2006) sensitivity of 87%,
specificity of 48%, positive predictive value of 90% and negative predictive
value of 40% was achieved with GB thickening > 3 mm. They also found
certain degree of correlation between thickening of the gallbladder wall > 5 mm
and the presence of acalculus cholecystitis. (35)
 33  patients  of  the  study  sample  showed  ascites  and  all  these  patients
developed CLS. None of the patients who did not develop CLS, showed ascites
while 63.3% were false negative revealing that though the positive predictive
value was 100%, negative predictive value was less. And hence the specificity
was 100% and senstivity was 36.6%.
Similarly, pleural effusion was seen in 44% of study patients and all these
patients developed CLS while pleural effusion was not seen in  patients who did
not develop CLS patients. But > 50% of CLS patients did not develop pleural
effusion and hence the sensitivity was 36.6% and negative predictive value was
15%.
Thus, in our study, gall bladder edema, ascites and pleural effusion were
seen in 60%, 36.7% and 48.9% respectively and these ultrasonographic features
were comparable to other studies.  In a study by Quiroz-Moreno, et al, (2006)
gallbladder thickening was present in 86% of the patients, pleural effusion in
66%, ascites in 60% and acute alithiatsic cholecystitis in 36%. (35)
Shruti  Chandak  and Ashutosh   Kumar, in  their study  to assess the
role of radiology in early diagnosis of Dengue Fever, found that the most
common ultrasound finding was hepatomegaly (62%), followed by
splenomegaly (45%), gallbladder (GB) wall edema (45%), right-sided pleural
effusion (37%), bilateral pleural effusion (22%), and ascites (36%).(36)
Similar results were found in study by Wu,  et  al where, sonographic
included thickened GB wall in 38 patients (59%), ascites in 24 patients (37%),
splenomegaly in 22(34%), pleural effusion in 21 patients (32%). (37) The most
common ultrasonographic feature was ascites (126, 74.6%) followed by gall
bladder wall edema (122, 72%), hepatomegaly (78, 46.2%), splenomegaly (66,
39.1%), pericholecystic collection (63, 37.3%); right side pleural effusion (48,
28.4%) and bilateral effusion (19,11.2%) in a study by Motla, et al. (38)
Sonographic findings included pleural effusion in 21 patients (53%), gall
bladder thickening in 17(43%) and mild ascites in 6 (15%) in a study by
Thulkar, et al.(39)
The most common ultrasonographic feature in the present study was GB
wall edema , which correlated well with studies by Quiroz-Moreno, et al (35) ,
Shruti Chandak (36) and Wu, et al (37) . But in studies by Motla, et al (38) and
Thulkar, et al, (39) the most common feature was ascites and pleural effusion
respectively.
Table 27   : Comparison of USG features in present study and other studies
USG
features
Present
study
Quiroz-
Moreno,
et al (35)
Shruti
Chandak
(36)
Wu, et al
(37)
Motla,
et al (38)
Thulkar,
et al (39)
GB
edema
60% 86% 45% 59% 72% 43%
Ascites 36.7% 60% 36% 37% 74.6% 15%
Pleural
effusion
48.9% 66% 37% 32% 28.4% 53%
PORTAL VEIN DOPPLER FEATURES:
There are many studies relating the ultrasonographic features in capillary
leak syndrome, but there are not many studies on the portal Doppler changes
during plasma leak phase of dengue fever. Since the dengue fever causes
immune mediated sinusoidal endothelial or Kupffer cells injury resulting in
obstruction to the hepatic sinusoidal capillary lumen and thus increasing the
resistance in hepatic sinusoidal capillary network . This increase in sinusoidal
resistence has a direct effect on the portal vein, which supplies 80% of the blood
to liver and thus can be easily demonstrated by portal venous Doppler studies.
Back pressure on the portal vein causes dilatation of the lumen and
reduction in the velocity which eventually leads to reversal of flow. A mean
portal vein diameter value of 12.884 was found in the patients who developed
CLS while a mean value of  11.310 was noted in the patients who did not
develop CLS. Area under the ROC curve was 0.729 with a standard error of
0.0989 and 95% confidence interval of 0.631 to 0.813. Using the ROC curve, a
optimal criterion of >11.2mm was formulated and the sensitivity was 75.6%
while specificity was 70%.
As the portal vein diameter increases, so as the cross-sectional area of
portal vein. Patients who developed CLS had a mean cross-sectional area value
of 1.4748 cm2 while the non CLS patients had a mean value of 1.1340. Hence
with a criterion of >1.25 cm2 the sensitivity was 61.1%   while specificity was
80% and area under the ROC curve was 0.718 with a standard error of 0.0744
and 95% confidence interval of 0.619 to 0.803.
This was in correlation with the study conducted in a large series of
normal patients to assess the portal vein measurements where the overall mean
diameter in 107 patients aged 21 -40 years was 11 ± 2 mm and  no difference
between the portal venous measurements of male and female patients.(40)
A study conducted in Nigeria to   determine   Portal Vein Diameter in
Adult Patients with Chronic Liver Disease, the mean diameter of the main PV
(±SD) in CLD was 18.68 ± 2.59 mm which is higher than that of the control
(10.87 ± 0.81 mm). (41) It was also seen in another study conducted in Ethopia,
that normal mean portal vein diameter was 10.6 mm ±1.8 SD with a
respirophasic variation of 25.6%. (42)
Portal vein velocity was reduced in patients who developed CLS in our
study. A mean value of 18.27 cm/sec was found in the patients who developed
CLS while a mean value of 25.10 cm/sec was noted in patients who did not
develop CLS. 93.3% sensitivity and 60% specificity was achieved with a
criterion of <25cm/sec and the area under curve was 0.781.
However, in a study by Khongphatthanayothin A, et al to investigate
the role of Doppler study of the portal vein as a predictor for capillary leakage
in dengue fever patients, it was found that   sensitivity was 72%, specificity was
79%  with  a  cut  off  of  <  15.3  cm/s  and  area  under  ROC  curve  was  0.88.  The
criterion of <15.3cm/s was taken in this study, as the study was conducted in
paediatric population. (43)
Congestive index, calculated from the ratio of the cross-sectional area of
the portal vein (cm2) and the average flow velocity (cm/sec), looks at the
increase in the cross-sectional area of the portal vein and the reduction in
velocity. In this study, the increased cross-sectional area and reduced portal
velocity yielded in increase in congestive index and so, the mean congestive
index in patients who developed CLS was 0.09724 and in non CLS patients
mean value was 0.04771. With a criterion of >0.0706 the sensitivity was 55.6%
while specificity was 100%.
Khongphatthanayothin A, et al, in another study revealed that the portal
vein was significantly more dilated, portal vein blood flow velocity was lower
and congestion index was higher in patients with shock (DSS) than DHF
without shock and than DF. (44)
LABORATORY FINDINGS
A mean platelet value of 49900 was found in the patients who developed
CLS while the non CLS patients had a mean value of 96040. Both these groups
had platelets  less than 1 lakh,   as  fever with thrombocytopenia was one of  the
inclusion criteria in this study. However, it is proved that the severity of dengue
fever depended predominantly on the degree of platelet destruction. More the
platelet destruction, more is the chances for developing capillary leak syndrome.
In another study, in most of the cases, ascites and pleural effusion developed
when platelet count is below 50,000/cm, inferring the inverse relation between
platelet count and capillary leak syndrome. (45)
A mean haematocrit value of 36.778 was found in the patients who
developed CLS while the non CLS patients had a mean value of 34.100. With a
criterion of    >37.4   the sensitivity was 43.3%   while specificity was 100%. A
mean haemoglobin value of 12.317 g was found in the patients who developed
CLS while the non CLS patients had a mean value of 11.400g. Area under the
ROC curve was 0.667 with a standard error of 0.0550 and 95% confidence
interval  of  0.566  to  0.758,  With  a  criterion  of    >12.5g    the  sensitivity  was
46.7%   while specificity was 100%.
COMPARISON OF THE FEATURES EVALUATED:
The  sensitivity  of    GB  wall  edema,  ascites  and  pleural  effusion  were
60%, 36.6% and 48.9 % while the specificities were 90%, 100% and 100%
respectively. All the ultrasonographic features had a high specificity and
positive predictive value, 98.1%, 100%, 100%. Since the false negative
frequencies were high, the features showed a less negative predictive value,
20%, 15%, 17.8% and the diagnostic accuracies yielded were 63%,43%, and
54% for GB wall edema, ascites and pleural effusion respectively.
The  sensitivity  of    PV  diameter,  PV  Velocity,  cross  sectional  area  and
congestive index were 75.6%, 93.3%, 61.1% and 55.6 % while the specificities
were 70%, 60%, 80% and 100% respectively. PV Velocity had the highest
sensitivity than other features, while congestive index showed 100% specificity.
This was also inferred from the binary logistic analysis where PV Velocity had
the maximum significance among all the portal vein Doppler indices.
Comparing the ultrasonographic features and portal Doppler features, it
was found in our study that Ultrasonographic features had an increased
specificity, but low sensitivity, while, portal Doppler features showed increase
in sensitivity, thus revealing the reduction in false negative rate. Thus the
diagnostic accuracy would increase when the ultrasonography is combined with
portal venous Doppler to predict the Capillary leak syndrome in dengue fever
patients.
The sensitivity and specificity of ultrasonographic features were similar to
sensitivity and specificity of laboratory findings, but the area under curve was
higher than the laboratory findings, thus revealing the higher efficiency of
imaging features than laboratory findings in predicting the occurrence of
capillary leak syndrome. This correlated with the study conducted to analysis
the newly proposed WHO classification, where hemoconcentration could detect
plasma leakage in 44.7% and CXR added up evidence of plasma leakage to
86.3%. while Ultrasonography was the most sensitive technique to add evidence
of plasma leakage up to 100%. (46)
Similar results were found in another study in 35 dengue hemorrhagic
fever patients where hemoconcentration (>20%) was detected in 20 cases
(57.14%) while ultrasonographic evidence of plasma leakage was seen in 32
cases (91.42%). (47) In another study, sonographic evidence of fluid collection
was seen in over half of subjects infected with dengue virus who did not show
any evidence of dengue hemorrhagic fever. (48) Similar  correlation  was  also
found with a study which resulted in earlier detection of plasma leak by
ultrasonography than hemoconcentration as demonstrated by positive USG
features in 12 of 17 DHF cases, who did not demonstrate the criteria for
significant hemoconcentration.(49)
In our study , few of the patients showed positive Doppler findings , even
when  the haematocrit  was found to be normal .  This  was stastistically proved
by the Analysis of  ROC curves of Portal Doppler features, which revealed that
the minimum area under curve was 0.718 in cross sectional area and maximum
was 0.827 in congestive index. But the area under curve for haematocrit and
haemoglobin were 0.666 and 0.667, which was significantly less than Portal
Doppler venous features. Thus revealing the importance of portal Doppler study
in early prediction of the capillary leak syndrome than the laboratory values like
haematocrit and haemoglobin.
CONCLUSION
In our study, the sensitivity of   GB wall edema, ascites and pleural
effusion were 60%, 36.6% and 48.9 % while the specificities were 90%, 100%
and 100% respectively. All the ultrasonographic features had a high specificity
and positive predictive value, 98.1%, 100%, 100% and since the false negative
frequencies were high, the features showed a less negative predictive value,
20%, 15%, 17.8% and the diagnostic accuracies yielded were 63%,43%, and
54% for GB wall edema, ascites and pleural effusion respectively.
 The sensitivity of    PV diameter,  PV Velocity,  cross sectional  area and
congestive index were 75.6%, 93.3%, 61.1% and 55.6 % while the specificities
were 70%, 60%, 80% and 100% respectively.
Comparing the ultrasonographic features and portal Doppler features, it
was found in our study that Ultrasonographic features had an increased
specificity, but low sensitivity, while, portal Doppler features showed increase
in sensitivity, thus revealing the reduction in false negative rate. Thus the
diagnostic accuracy would increase when the ultrasonography is combined with
portal venous Doppler to predict the Capillary leak syndrome in dengue fever
patients.
The area under ROC curve of ultrasonographic features were higher than
the laboratory findings, thus revealing the higher efficiency of imaging features
than laboratory findings in predicting the occurrence of capillary leak
syndrome.
The area under ROC curve of  Portal Doppler features ranged from 0.718
to 0.827, but  the area under curve for haematocrit and haemoglobin were 0.666
and 0.667, which was significantly less than Portal  Doppler venous features.
Thus revealing the importance of portal Doppler study in early prediction of the
capillary leak syndrome than the laboratory values like haematocrit and
haemoglobin.
Thus , imaging has an important role in the early diagnosis of capillary
leak syndrome in dengue fever patients. Ultrasonography aids in the early
detection of manifestations of plasma leak. Combined use of USG and Portal
Doppler study features like portal vein diameter, velocity, cross sectional area
and congestive index increases the detection rate and thus aids in the early
treatment of capillary leak syndrome, thereby reducing the morbidity and
mortality of dengue fever, inspite of normal haematocrit and haemoglobin
values.
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LIST OF ABBREVIATIONS
? DF - Dengue fever
? DHF - Dengue hemorrhagic fever
? DSS - Dengue shock syndrome
? CLS - Capillary leak syndrome
? USG - Ultrasonogram
? PV - Portal vein
? CSA - Cross sectional area
? GB - Gallbladder
? NVDCP - National vector bone disease control
           programme
? WHO - World health organization
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sponsor’s behalf, the ethical committee and the regulatory authorities will not
need my permission to look at my health records, both in respect of the current
study and any further research that may be conducted in relation to it, even if I
withdraw from the study I agree to this access. However I understand that my
identity would not be revealed in any information released to third parties or
published, unless as required under the law. I agree not to restrict the use of any
data or results that arise from this study.
I hereby consent to participate in this study.
I hereby give permission to undergo complete clinical examination and
diagnostic tests including haematological, biochemical and followed by
radiological tests .
Patient’s signature/thumb impression:
Patient’s name and address:
Place:                              Date:
Signature of the investigator: Name of the investigator:
Place:                              Date:
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??? ???????? ?????: ???? ?????? ??????? ?? ? ?????
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“PROSPECTIVE STUDY OF ROLE OF PORTAL VENOUS DOPPLER IN PREDICTING
CAPILLARY LEAK SYNDROME IN DENGUE FEVER PATIENTS ”
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????? ???? ??? ??? ? ?? ??? ???? ??? ???????????
???? ??? ????????? ?? ???? ???? ?? ?? ??? ????
?????? ??????????????? ?? ??.
2) ??? ????? ?? ????? ??? ?????? ?? ??????
????? ?????? ????? ???? ???? ?? ??? , ??? ?????
?? ??????????????? ?????????????????? ??.
3) ???? ?????? ?? , ??? ???? ? ?? ???? ?? ???? ??
???? ???? ????? ??? ??? ??. ??? ???? ??????
???? ? ??? ???????? ?????????.
4) ??????? ???????? ??? ?? ?? ??????????????????
???????? ?? ??
?????????? ???????
????: ????:
?????????? ???????
????????: ????????:
?? ???: ????:
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S.No Name of the patient Age Sex IP No GB wall edema GB wall thickness[mm] Ascites Pleural effusion PV Diameter PV Velocity[cm/sec] Cross sectional area[Cm2] Congestion index Platelet count Haematocrit /
 PCV
Hb% CLS
1 KAVITHA 32 F 58139 YES 4.1 NO NO 14.8 28 1.47 0.0525 25000 58.6 19.6 YES
2 RENUKA 24 F 58152 YES 3.8 NO NO 10.8 21 1.36 0.064761905 73000 37 11.9 YES
3 JENISHA 18 F 58433 NO 2.7 NO NO 14.5 17 1.4 0.082352941 93000 32.1 9.7 YES
4 PRIYA 23 F 58512 NO 1.7 NO NO 10.8 16 1.2 0.075 44000 37.7 13.1 YES
5 DEEPAN 23 M 59002 YES 3.9 YES YES 9.3 19.4 1.12 0.057731959 75000 38.4 12.6 YES
6 MONIKA 20 F 59131 NO 1.9 NO NO 12.5 18 1.25 0.069444444 56000 29.8 11.5 NO
7 PAVITHRAN 15 M 58435 YES 3.6 YES YES 12.6 11 1.12 0.101818182 83000 34.9 13.5 YES
8 SRI VIDYA 29 F 58776 YES 3.9 YES YES 15 12.2 2.2 0.180327869 76000 37.4 12.1 YES
9 PACHAIYAMMAL 45 F 58943 YES 3.4 YES YES 10.1 21 1.3 0.061904762 66000 36.3 10.3 YES
10 JHONSON 22 M 57905 NO 2.1 NO NO 10.3 23 1.35 0.058695652 116000 35.7 13 YES
11 LATHA 23 F 58911 NO 2.3 NO NO 9.2 27 0.9 0.033333333 92000 35.9 11.5 NO
12 VIJAYA 30 F 59121 NO 1.6 NO NO 9.5 30 0.87 0.029 195000 37.4 11.6 NO
13 KANIPRIYA 27 F 59144 YES 3.5 NO NO 10.2 23 1.27 0.055217391 41000 41.6 13.7 YES
14 FATHIMA 27 F 59165 YES 3.6 YES NO 13 19 2.1 0.110526316 30000 40.8 14.6 YES
15 BHUVANESHWARI 18 F 59210 NO 1.5 NO NO 10.6 20 1.2 0.06 32000 34 11.7 YES
16 SOUNDARYA 14 F 59242 YES 2.9 YES YES 14.3 22 1.4 0.063636364 36000 37 11 YES
17 SAGUNTHALA 25 F 58926 YES 3.5 YES YES 10 13 1.2 0.092307692 72000 38.5 12.8 YES
18 TAMILVANI 19 F 58455 YES 4.5 YES YES 11.6 20.7 0.96 0.046376812 53000 39.5 12.9 YES
19 ANJALAI 14 F 58462 YES 3.7 NO YES 11.3 22.6 0.88 0.038938053 59000 31 11.6 YES
20 ERUSAPPAN 25 M 58512 YES 2.7 NO NO 14.1 19 1.72 0.090526316 79000 36.4 10.1 YES
21 POPPY 35 F 58543 YES 3.9 YES YES 15 18.4 2.1 0.114130435 22000 43.5 14.9 YES
22 SELVAM 32 M 58415 YES 3.6 YES YES 12.6 24 1.5 0.0625 41000 36.5 13.5 YES
23 SUSHMITHA 19 F 58476 YES 4.3 YES YES 13.1 22 1.9 0.086363636 9000 37 12.6 YES
24 KOWSALYA 20 F 58763 YES 2.9 NO NO 9.5 17 0.69 0.040588235 12400 31.3 11.2 NO
25 ANAND 24 M 58825 YES 3.4 YES YES 16 9 2.3 0.255555556 15000 36.6 12.6 YES
26 DIVYA BHARATHI 20 F 58235 NO 1.3 NO NO 12.6 11.7 1.1 0.094017094 65000 40.5 13.3 YES
27 PADMA 37 F 58287 NO 1.6 NO NO 14.8 12 2.8 0.233333333 34000 42.7 14.3 YES
28 JANAKIRAMAN 29 M 59565 YES 2.7 NO YES 10 19 1.1 0.057894737 15000 35.4 11.2 YES
29 INDHRA 37 F 59980 NO 1.2 NO NO 12 19 1.2 0.063157895 97000 32.9 11.2 YES
30 SHARMILA 25 F 59856 YES 3.1 YES YES 10 21 0.74 0.035238095 43000 41.8 14.8 YES
31 GRACE 27 F 60187 YES 5.3 YES YES 12 6.5 1.4 0.215384615 56000 42.8 14.1 YES
32 KUMAR 42 M 59342 YES 4.5 NO YES 14 17.2 1.1 0.063953488 160000 36.1 12.1 YES
33 PADMAPRIYA 37 F 59490 NO 1.1 NO NO 10 19 1.12 0.058947368 74000 29.4 8.9 YES
34 PAVITHRA 23 F 59694 YES 5.3 YES YES 11 16 1.3 0.08125 66000 35.5 11.7 YES
35 POMANI 18 M 59563 NO 1.4 NO NO 11.4 21 1.2 0.057142857 42000 30.8 9.3 YES
36 SRIDEVI 29 F 56782 NO 2.3 NO NO 11.2 17 1.2 0.070588235 106000 34.3 11.3 NO
37 KOWSALYA 41 F 59555 YES 3.6 NO YES 11.8 21 0.96 0.045714286 53000 35.2 11.7 YES
38 RAJA 30 M 59571 YES 4.7 NO YES 13 16 1.2 0.075 48000 31.6 10.5 YES
39 SASIKALA 35 F 58543 YES 3.8 NO YES 11.2 17 1.4 0.082352941 22000 31 11.4 YES
40 BENESHA 31 F 58342 YES 6.6 NO YES 13 15.2 1.06 0.069736842 102000 36.1 11.5 YES
41 VEERAMANI 35 M 57893 YES 5.4 NO YES 12 1.8 1.34 0.744444444 34000 31.9 11.7 YES
42 ANANDHI 35 F 60482 NO 1.8 NO NO 12.6 22 1.8 0.081818182 13000 30.3 9.3 YES
43 SHEELA 40 F 60188 NO 1.6 NO NO 13 15 1.1 0.073333333 19000 32.9 11 YES
44 DHEENA 13 M 60321 NO 1.4 NO NO 10 26 1.1 0.042307692 72000 36.4 12 NO
45 POONGOTHAI 32 F 60031 YES 6.2 YES YES 15.5 11.3 1.4 0.123893805 10000 33.3 12.6 YES
46 LALITHA 39 F 60564 YES 6.2 YES YES 15.2 17.2 2.2 0.127906977 22000 34 11.4 YES
47 PATCHAIYAMMAL 51 F 60676 YES 7 NO NO 12 12.4 0.98 0.079032258 34000 22.3 7.4 YES
48 SENTHAMARAIKANNAN 42 M 60511 YES 4.2 YES YES 17.5 14 2.44 0.174285714 43000 45.9 14.9 YES
49 LATHA 37 F 60147 YES 8.7 NO YES 15.4 12.8 2.28 0.178125 86000 39.7 13.6 YES
50 VAANMATHI 20 F 60881 NO 1.8 NO NO 14 24 1.57 0.065416667 21000 25.4 10.9 YES
51 POOJA 24 F 60663 NO 1.7 NO NO 11.2 24 0.76 0.031666667 15000 31.5 10.8 YES
52 VALLILNAYAGAM 44 M 60740 YES 4.6 NO NO 12.1 24 1.96 0.081666667 31000 40.2 13 YES
53 PARVATHY 23 F 60563 YES 7 NO YES 11 18.7 1.62 0.086631016 23000 35.2 12.1 YES
54 KARUPPAN 34 M 60772 YES 10 YES YES 13.7 14.8 2.3 0.155405405 22000 33.2 10.6 YES
55 KANNIYAPPAN 28 M 60342 NO 1.2 NO NO 13.6 30 1.7 0.056666667 45000 39.2 10.4 YES
56 MANIMEGALAI 28 F 60812 NO 1.5 NO NO 11 33 1.1 0.033333333 52000 35.8 11.4 NO
57 ESWARAN 26 M 60576 NO 2.1 NO NO 14.3 24.5 1.82 0.074285714 60000 30.7 10.9 YES
58 SANDHIYA 21 F 60375 NO 2.4 NO YES 11 18 1.1 0.061111111 20000 33.7 12.1 YES
59 DURGA 24 F 60964 YES 4 NO YES 12 15 1.6 0.106666667 47000 40.1 13 YES
60 PRIYANKA 29 F 60911 NO 2.9 NO NO 13 22.3 1.6 0.071748879 66000 34.3 10.8 YES
61 SRINIVASAN 40 M 60974 YES 4 NO NO 11 19 1.2 0.063157895 19000 32.9 11 YES
62 VIJI 43 M 60481 YES 5.4 NO NO 9 22 0.8 0.036363636 15000 30.5 9.7 YES
63 AMUTHA 39 F 60732 YES 6.2 YES YES 13.3 16 2.12 0.1325 10000 13.2 10 YES
64 SANTHOSHAM 35 M 60542 YES 5.8 YES YES 16.1 10.5 1.92 0.182857143 14000 37.4 12.8 YES
65 DHAYA 19 M 60753 NO 1.6 NO NO 11.4 25 0.86 0.0344 23000 43.3 14.9 YES
66 GEETHA 45 F 71113 NO 2.4 NO NO 14.6 28.4 1.52 0.053521127 59000 25.4 8.2 YES
67 SEETHARAMAN 35 M 60971 YES 4 YES YES 11 22 1.2 0.054545455 80000 35.1 12.3 YES
68 DEVI 29 F 60874 NO 2.1 NO NO 12 28.2 1.6 0.056737589 29000 36.7 12.6 YES
69 ASHWIN 20 F 71116 NO 1.9 NO NO 10.1 24.5 0.98 0.04 64000 30.2 10.2 YES
70 SANGAVI 23 F 71254 NO 1.9 NO NO 11.8 27.5 1.06 0.038545455 133000 32.2 11.1 YES
71 LALITHA.M 32 F 71284 NO 1.8 NO NO 14.1 19.5 1.6 0.082051282 41000 38.3 13.7 YES
72 VINITHA 19 F 71432 YES 5.6 YES YES 11.6 10.1 2.3 0.227722772 72000 35.5 11.8 YES
73 SUMITHRA 25 F 71465 NO 2.3 NO NO 14.1 23 1.7 0.073913043 57000 34 10.7 YES
74 USHA 31 F 71417 NO 2.1 NO NO 14.9 16.5 1.45 0.087878788 18000 39.3 13.4 YES
75 KEERTHI VARMAN 18 M 71534 NO 2.8 NO NO 11.6 21 1.2 0.057142857 102000 28.3 9.4 YES
76 NAVEEN 19 M 71499 NO 1.5 NO NO 11.2 24 1.2 0.05 114000 27.7 8.7 YES
77 MAYAVATHI 21 F 71987 YES 9.1 NO YES 14 22 0.84 0.038181818 41000 40.9 14.6 YES
78 KALPANA 25 F 71243 NO 1.4 NO NO 13.4 16 1.4 0.0875 113000 28 10 YES
79 SARATHY 17 M 71122 YES 5.2 NO YES 14 22 1.6 0.072727273 45000 44.9 15 YES
80 LAKSHMI 38 F 71670 NO 2.1 NO NO 14.9 31 1.6 0.051612903 220000 33.8 10.2 NO
81 RENUKA 45 F 71988 NO 3 NO NO 11 31 1.2 0.038709677 95000 35.8 12.5 NO
82 THIRUVENKADAM 24 M 71187 NO 2.5 NO NO 14.4 12.78 1.99 0.15571205 165000 41.7 13 YES
83 AJITHKUMAR 20 M 71828 YES 11.4 YES YES 15.2 15.5 1.65 0.106451613 25000 42.1 12.5 YES
84 SURENDAR 28 M 70079 NO 1.9 NO NO 15.1 15.7 1.09 0.069426752 42000 43.7 13.1 YES
85 SARATHY 15 M 71122 NO 2.1 NO NO 13.7 21 1.61 0.076666667 131000 41.2 11.8 YES
86 ASPHAR 36 M 71709 NO 2 NO NO 10 20 1.3 0.065 26000 32.2 12.3 YES
87 BALU 17 M 74171 YES 9.2 YES YES 15.5 16.38 2.47 0.150793651 18000 45.6 15.5 YES
88 KRISHNAMOORTHY 25 M 73155 NO 2.7 NO NO 13.3 13.2 0.82 0.062121212 24000 43.8 16 YES
89 YASHWANTH 15 M 73945 YES 5 YES YES 12.2 20 1.12 0.056 30000 39.5 13.3 YES
90 RIAS 17 M 74128 YES 5.9 NO NO 14.5 16 1.39 0.086875 23000 45 12.5 YES
91 KEERTHI VARMAN 14 F 73781 NO 1.9 NO NO 12.8 18.7 0.92 0.049197861 45000 38.7 11.3 YES
92 DHANUSH 19 M 74033 YES 8.6 YES YES 16.5 13.6 2.12 0.155882353 28000 40.8 13.1 YES
93 THEERKADHARISI 20 F 71899 YES 12.8 YES YES 14.2 15.6 1.87 0.119871795 50000 40.2 14.1 YES
94 PRIYA 22 F 74169 NO 1.71 NO NO 16.8 19.5 1.41 0.072307692 25000 44.8 13.8 YES
95 SARASWATHY 33 F 74567 YES 4.4 YES YES 14.7 11.7 1.63 0.139316239 27000 41.8 14.3 YES
96 BHARATH 18 M 74757 YES 7.4 YES YES 14 11.7 1.6 0.136752137 30000 45.3 15 YES
97 AMANULA 37 M 74744 YES 9 YES NO 14.3 12 1.51 0.125833333 21000 49.1 17.5 YES
98 KASI 21 M 74369 YES 5.6 YES YES 14.6 11.7 2.3 0.196581197 15000 41.6 14 YES
99 FAIZAL ANSARI 22 M 74192 NO 2.1 NO NO 14.3 21 1.43 0.068095238 60000 30.5 10.8 NO
100 MOHAMMED HUSSAIN S M 74122 NO 1.1 YES NO 12.7 27.6 1.08 0.039130435 89000 43 15 YES


